Authorizes registered pharmacy technicians to administer the same immunizations as licensed pharmacists under direct supervision of such licensed pharmacist.
S 8334 requires health insurance plans to cover all recommended doses of the COVID-19 vaccine (SARS-CoV-2), adding it to a list of mandatory immunizations already covered by New York insurance law. This affects insurance companies, healthcare providers, and patients by mandating reimbursement for the vaccine without cost-sharing. The bill amends multiple sections of New York’s insurance and social services laws to include "severe acute respiratory syndrome coronavirus 2" in required coverage, aligning with federal standards for biological products. It applies to all insurance contracts effective January 1 after the law takes effect.
This bill requires New York's health department to create and operate a free mobile application for individuals eligible for Medicaid who are pregnant, postpartum, or planning pregnancy. The app must provide New York-specific resources, links to state programs, and support in multiple languages, with strict privacy protections prohibiting personal data sharing. Developers must report anonymized usage data (like user numbers and engagement) to state lawmakers. The app will be available across mobile platforms and must comply with state health resource standards.
Provides that the commissioner of education may promulgate rules and regulations for a health education curriculum to include menstrual disorders, including but not limited to, endometriosis.
Establishes a quality incentive program for managed care providers that is distributed based on managed care providers' performance in meeting quality objectives.
This bill requires insurers and health care plans to follow specific rules when using virtual credit cards or fee-based digital payment methods to reimburse healthcare providers. Insurers must first notify providers of any potential fees, offer a fee-free payment alternative, and get the provider's written consent within 30 days to use the fee-based method. If a provider doesn't respond in time, insurers must default to the fee-free option. The law applies directly to insurers and healthcare providers who contract with them, ensuring transparency and preventing unexpected charges for providers.
This bill establishes legal confidentiality for conversations between police officers and peer support specialists during official counseling sessions. It directly affects law enforcement officers seeking mental health support and the peer support specialists who provide it. Key provisions prohibit disclosing session details unless there's a specific threat of suicide, self-harm, violence, or child abuse - allowing limited disclosure only to prevent harm. Officers must receive written notice before sessions explaining these confidentiality rules and exceptions. The law ensures peer support communications remain private except in clearly defined safety emergencies.
This bill (A 9491) requires courts and mental health institutions to coordinate discharge planning for defendants in criminal cases terminated due to mental disease or defect. It mandates that courts order referrals to community services (when clinically appropriate and with consent) and dismiss charges upon termination, while institutions must track referrals and submit de-identified annual reports to state officials. The mental hygiene law office must publish annual public data on defendant outcomes, including admission rates, discharge planning, and referral patterns. The bill directly affects defendants in such cases, courts, mental health facilities, and state agencies, without altering eligibility for services or requiring referrals where consent is absent.
Relates to requiring a medical facility or related service to obtain express prior written consent before filming and/or broadcasting of visual images of a patient's medical treatment.
This bill allows licensed pharmacists to order and administer specific medical tests, including COVID-19, flu, RSV, strep throat, HbA1c, hepatitis C, and HIV tests, all authorized by the FDA. It directly affects pharmacists (expanding their clinical role) and patients (increasing access to convenient testing). The law requires tests to meet FDA authorization and federal "waiver" requirements, aligning pharmacists with qualified health professionals under existing public health law. The bill modifies prior 2022 legislation but includes a sunset provision, with most provisions set to expire on July 1, 2028.